ZANZALINTINIB
UNII KC2JC2ZA04

Substance Identification & Data

This profile provides standardized clinical and technical data for Zanzalintinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KC2JC2ZA04.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2367004-54-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KC2JC2ZA04

CAS Registry Number

2367004-54-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZANZALINTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H25FN4O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JSPCKALGNNVYOO-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C161598

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

139350422

Unique identification number in the NCBI database of chemical substances.

INN ID

12299

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-119

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(NC(C2(CC2)C(=O)Nc3ccc(cc3)Oc4ccnc5cc(c(cc45)C(NC)=O)OC)=O)ccc(F)cc1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zanzalintinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.